Q4 2025 earnings call: 2026 revenue guidance $900M–$1B, FDA relacorilant setback, ROSELLA win, generic risks—read now.

We're transitioning from building a pipeline to building a business." He highlighted the successful launch of PALSONIFY as the company's first commercial product and emphasized its label reflecting ...

Crinetics Pharmaceuticals (NASDAQ:CRNX) executives highlighted early commercial momentum for PALSONIFY, outlined a global phase II/III study plan for atumelnant in ACTH-dependent Cushing’s syndrome ...

Net Product Revenue of $5.4 Million for Fourth-Quarter 2025, with >200 Enrollment Forms at the End of December Operationally Seamless Phase 2/3 Study of Atumelnant for the Treatment of ACTH-Dependent ...

“I love this woman more than life itself,” Glenn Marsh tells PEOPLE of wife Alecia Wendland ...

Dry, itchy skin is one of the most common discomforts affecting dogs and cats.

Midos Sujin Tonmainin, manufactured by Nam King Drugs Malaysia was found to be adulterated with Dexamethasone/Betamethasone.

A recent longitudinal cohort study shows a statistically significant relationship between body image disturbance, pain, and persistent depression in patients with Cushing syndrome.

Equine Cushing’s disease is one of the most common disease syndromes to affect horse health, according to the National Equine Health Survey in 2018*. It is estimated that 20% of horses and ponies over ...

John Davidson’s use of derogatory language during the BAFTA Awards was a symptom of the highly misunderstood neurological ...

Scientists from Duke-NUS Medical School, working with collaborators at Imperial College London and partners in Europe and the United States, have uncovered new insights into how an additional copy of ...